ENTA•benzinga•
Enanta Pharma To Present Data From Phase 2 Study Of Zelicapavir In Children With Respiratory Syncytial Virus At 43rd Annual ESPID Meeting
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 22, 2025 by benzinga